138 related articles for article (PubMed ID: 29333018)
21. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
[TBL] [Abstract][Full Text] [Related]
22. Tolerance and toxicity of neoadjuvant docetaxel, cisplatin and 5 fluorouracil regimen in technically unresectable oral cancer in resource limited rural based tertiary cancer center.
Patil VM; Chakraborty S; Shenoy PK; Manuprasad A; Sajith Babu TP; Shivkumar T; Babu S; Bhatterjee A; Balasubramanian S
Indian J Cancer; 2014; 51(1):69-72. PubMed ID: 24947100
[TBL] [Abstract][Full Text] [Related]
23. Management and outcome of locally advanced oral squamous cell carcinoma.
Bera RN; Tandon S; Singh AK; Boojar FMA; Jaiswal G; Borse S; Pal US; Sharma NK
Natl J Maxillofac Surg; 2023; 14(2):185-189. PubMed ID: 37661995
[TBL] [Abstract][Full Text] [Related]
24. Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.
Patil VM; Noronha V; Joshi A; Muddu VK; Dhumal S; Arya S; Juvekar S; Pai P; Chatturvedi P; Devendra AC; Ghosh S; D'cruz A; Kumar P
Indian J Cancer; 2014; 51(1):20-4. PubMed ID: 24947091
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
Nakahara S; Takenaka Y; Ogawa K; Nishiike S; Yamamoto Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Yoshii T; Tomiyama Y; Inohara H
Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
[TBL] [Abstract][Full Text] [Related]
26. Impact of radical treatments on survival in locally advanced T4a and T4b buccal mucosa cancers: Selected surgically treated T4b cancers have similar control rates as T4a.
Mair MD; Sawarkar N; Nikam S; Sarin R; Nair D; Gupta T; Chaturvedi P; D'cruz A; Nair S
Oral Oncol; 2018 Jul; 82():17-22. PubMed ID: 29909893
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Determinants of Outcome in Pathologic T4a (pT4a) Squamous Cell Carcinoma of the Gingivobuccal Subsite of the Oral Cavity.
Jain PV; Sharan R; Manikantan K; Mallick I; Chatterjee S; Arun I; Arun P
Indian J Surg Oncol; 2019 Dec; 10(4):594-599. PubMed ID: 31857749
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma.
Rivera F; Galán M; Tabernero J; Cervantes A; Vega-Villegas ME; Gallego J; Laquente B; Rodríguez E; Carrato A; Escudero P; Massutí B; Alonso-Orduña V; Cardenal A; Sáenz A; Giralt J; Yuste AL; Antón A; Aranda E;
Cancer Chemother Pharmacol; 2011 Jan; 67(1):75-82. PubMed ID: 20198372
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Abdelmeguid AS; Teeramatwanich W; Roberts DB; Amit M; Ferraroto R; Glisson BS; Kupferman ME; Su SY; Phan J; Garden AS; Raza SM; DeMonte F; Hanna EY
Cancer; 2021 Jun; 127(11):1788-1795. PubMed ID: 33567468
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.
Inhestern J; Oertel K; Stemmann V; Schmalenberg H; Dietz A; Rotter N; Veit J; Görner M; Sudhoff H; Junghanß C; Wittekindt C; Pachmann K; Guntinas-Lichius O
PLoS One; 2015; 10(7):e0132901. PubMed ID: 26186556
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
32. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI
Cochrane Database Syst Rev; 2011 Apr; (4):CD006386. PubMed ID: 21491393
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy in oral cancers: Selecting the right patients.
Vishak S; Rangarajan B; Kekatpure VD
Indian J Med Paediatr Oncol; 2015; 36(3):148-53. PubMed ID: 26855522
[TBL] [Abstract][Full Text] [Related]
34. The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma.
Wang X; Li N; Meng J; Wen N
Am J Otolaryngol; 2021; 42(6):103112. PubMed ID: 34214712
[TBL] [Abstract][Full Text] [Related]
35. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Okano S; Enokida T; Onoe T; Ota Y; Motegi A; Zenda S; Akimoto T; Tahara M
Int J Clin Oncol; 2019 Jul; 24(7):789-797. PubMed ID: 30796560
[TBL] [Abstract][Full Text] [Related]
36. Induction Chemotherapy Improved Long Term Outcomes in Stage IV Locoregional Advanced Nasopharyngeal Carcinoma.
Wang YW; Ho SY; Lee SW; Chen CC; Litsu S; Huang WT; Yang CC; Lin CH; Chen HY; Lin LC
Int J Med Sci; 2020; 17(5):568-576. PubMed ID: 32210706
[No Abstract] [Full Text] [Related]
37. Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon.
Ramaswamy A; Jandyal S; Ostwal V; Engineer R; Lewis S; Bose S; Pande N; Shrikhande SV
Indian J Cancer; 2017; 54(3):530-534. PubMed ID: 29798952
[TBL] [Abstract][Full Text] [Related]
38. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
39. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
40. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M
Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]